CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Revenues:
Total Revenues	$ 207,443	$ 183,184
Forwarding expenses and cost of revenues:
Total forwarding expenses and cost of revenues	142,450	124,800
Gross profit	64,993	58,384
Operating Expenses:
Selling, general and administrative	55,871	52,327
Amortization of intangible assets	2,688	2,299
Total Operating Expenses	58,559	54,626
Income from Operations	6,434	3,758
Other Items:
Interest expense net of interest income	(2,073)	(2,318)
Other income (expense)	2,518	(346)
Income Before Income Taxes	6,879	1,094
Income tax benefit (expense)	(1,222)	(543)
Net income (loss)	5,657	551
Preferred stock dividends	(384)	(328)
Non-controlling interest dividends	(243)	0
Net Income Available to Common Stockholders	$ 5,030	$ 223
Net income per share:
Basic (in Dollars per share)	$ 4.77	$ 0.46
Diluted (in Dollars per share)	4.69	0.45
Net income per share attributable to common stockholders:
Basic (in Dollars per share)	4.24	0.19
Diluted (in Dollars per share)	$ 4.17	$ 0.18
Weighted average number of shares outstanding:
Basic (in Shares)	1,186,400	1,186,400
Diluted (in Shares)	1,205,400	1,206,200
Logistics [Member]
Revenues:
Total Revenues	$ 183,823	$ 159,958
Forwarding expenses and cost of revenues:
Total forwarding expenses and cost of revenues	134,760	117,501
Life Sciences and Manufacturing [Member]
Revenues:
Total Revenues	23,620	23,226
Forwarding expenses and cost of revenues:
Total forwarding expenses and cost of revenues	$ 7,690	$ 7,299